Dissolution analysis, including USP dissolution, is crucial to effective drug development. Yet traditional dissolution approaches can be inefficient and time-consuming, delaying progress and consuming resources. Pion dissolution testing equipment is engineered to support every step of the drug development process. Our in-situ solutions are used by 97% of the Big Pharma companies for rapid, cost-effective, predictive results aligned to today’s drug development methodology. Contact PION for more information or questions today!
Pion’s in situ fiber-optic UV dissolution monitoring system, specifically designed to monitor small volume concentrations.
Pion’s miniDISS Profiler™ is a Rainbow in situ Fiber Optic UV monitoring system with the miniDT dissolution tester and is designed for biorelevant media volumes.
Pion’s benchmark tool for in situ dissolution monitoring, designed to deliver the fastest path to accurate analysis.
Real-time imaging of the dissolution process for maximum insight.
A powerful and versatile formulation workstation for automated analysis of solutions, powders, suspensions, compacted pellets and dosages in situ.
Dissolution testing is a vital part of the drug development process. A dissolution test measures the extent and rate of drug release from a specified dosage form. During the test, formulation changes that affect the dissolution rate of a product are identified. The test is performed to ensure a drug complies with quality standards and specifications prior to release.
In addition to designing and manufacturing efficient dissolution chemistry instruments, we also service our equipment to the highest performance levels. Well-maintained equipment can increase the productivity and reliability of your apparatus.
Our center of excellence for production in the US holds an ISO 9001:2015 certification, which recognizes our products and services to meet customer needs through a robust quality management system. In addition, all Pion equipment comes with an initial one-year warranty for greater protection.
We can run a wide range of standardized assays and dissolution methods during the formulation phase of drug development.